On the public citation graph

Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu‐Asia Aging Study

0 signed · 158 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archneur.60.3.337openalex-snapshot
Neuronal Loss Is Greater in the Locus Coeruleus Than Nucleus Basalis and Substantia Nigra in Alzheimer and Parkinson Diseases
inferredcites →https://doi.org/10.1001/jama.1996.03540120033030openalex-snapshot
Prevalence of Dementia in Older Japanese-American Men in Hawaii
inferredcites →https://doi.org/10.1001/jama.272.21.1666openalex-snapshot
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study
inferredcites →https://doi.org/10.1001/jama.283.20.2674openalex-snapshot
Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease
inferredcites →https://doi.org/10.1002/1531-8257(199901)14:1<10::aid-mds1005>3.0.co;2-4openalex-snapshot
A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes
inferredcites →https://doi.org/10.1002/ana.10611openalex-snapshot
Alcohol consumption and the incidence of Parkinson's disease
inferredcites →https://doi.org/10.1002/ana.410410312openalex-snapshot
Pathological correlates of extrapyramidal signs in Alzheimer's disease
inferredcites →https://doi.org/10.1002/gps.548openalex-snapshot
Mild extrapyramidal signs and functional impairment in ageing
inferredcites →https://doi.org/10.1002/mds.20513openalex-snapshot
Clinical characteristics in early Parkinson's disease in a central California population‐based study
inferredcites →https://doi.org/10.1002/mds.21290openalex-snapshot
Lower low‐density lipoprotein cholesterol levels are associated with Parkinson's disease
inferredcites →https://doi.org/10.1002/sim.4780141908openalex-snapshot
Exact logistic regression: Theory and examples
inferredcites →https://doi.org/10.1006/bmmb.1993.1016openalex-snapshot
Decreased Cholesterol Biosynthesis in Fibroblasts from Patients with Parkinson Disease
inferredcites →https://doi.org/10.1007/978-1-4612-4380-9_37openalex-snapshot
Regression Models and Life-Tables
inferredcites →https://doi.org/10.1007/978-3-7091-6360-3_1openalex-snapshot
Post mortem studies in Parkinson’s disease — is it possible to detect brain areas for specific symptoms?
inferredcites →https://doi.org/10.1007/s00415-003-1306-7openalex-snapshot
Environmental, life-style, and physical precursors of clinical Parkinson?s disease: recent findings from the Honolulu-Asia Aging Study
inferredcites →https://doi.org/10.1016/0021-9681(70)90022-6openalex-snapshot
Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration
inferredcites →https://doi.org/10.1016/1047-2797(91)90005-wopenalex-snapshot
The cardiovascular health study: Design and rationale
inferredcites →https://doi.org/10.1016/s0022-2275(20)41611-6openalex-snapshot
Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.
inferredcites →https://doi.org/10.1016/s0140-6736(01)05553-2openalex-snapshot
Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study
inferredcites →https://doi.org/10.1016/s0197-4580(02)00057-xopenalex-snapshot
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
inferredcites →https://doi.org/10.1016/s0197-4580(02)00065-9openalex-snapshot
Staging of brain pathology related to sporadic Parkinson’s disease
inferredcites →https://doi.org/10.1017/s1041610294001602openalex-snapshot
The Cognitive Abilities Screening Instrument (CASI): A Practical Test for Cross-Cultural Epidemiological Studies of Dementia
inferredcites →https://doi.org/10.1093/aje/kwj283openalex-snapshot
Serum Cholesterol Levels and the Risk of Parkinson's Disease
inferredcites →https://doi.org/10.1093/clinchem/18.6.499openalex-snapshot
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
inferredcites →https://doi.org/10.1093/oxfordjournals.aje.a113787openalex-snapshot
TEN-YEAR INCIDENCE OF CORONARY HEART DISEASE IN THE HONOLULU HEART PROGRAM
inferredcites →https://doi.org/10.1093/oxfordjournals.aje.a114019openalex-snapshot
LOGISTIC REGRESSION IN SURVIVAL ANALYSIS
inferredcites →https://doi.org/10.1093/oxfordjournals.aje.a116960openalex-snapshot
Prospective Study of Cigarette Smoking and the Risk of Developing Idiopathic Parkinson's Disease
inferredcites →https://doi.org/10.1097/00019052-200008000-00010openalex-snapshot
Epidemiology of Parkinsonʼs disease and akinetic syndromes
inferredcites →https://doi.org/10.1111/j.2517-6161.1972.tb00899.xopenalex-snapshot
Regression Models and Life-Tables
inferredcites →https://doi.org/10.1186/1741-7015-5-20openalex-snapshot
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
inferredcites →https://doi.org/10.1212/01.wnl.0000130159.28215.6aopenalex-snapshot
APOE-ε2 allele associated with higher prevalence of sporadic Parkinson disease
inferredcites →https://doi.org/10.1212/wnl.37.5.893openalex-snapshot
Recent Developments in Parkinson's Disease
inferredcites →https://doi.org/10.1212/wnl.53.3.517openalex-snapshot
APOE genotype, plasma lipids, lipoproteins, and AD in community elderly
inferredcites →https://doi.org/10.1212/wnl.57.3.456openalex-snapshot
Frequency of bowel movements and the future risk of Parkinson’s disease
inferredcites →https://doi.org/10.1212/wnl.66.10_suppl_4.s10openalex-snapshot
Etiology of Parkinson’s disease
inferredcites →https://doi.org/10.2307/2530043openalex-snapshot
Analysis of Covariance and Standardization as Instances of Prediction

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4754860openalex-extracted
Sexual Dimorphism on the Role of Lipid and Apolipoprotein Traits in the Risk of Parkinson's Disease
inferred← citeshttps://doi.org/10.1001/archneurol.2010.321openalex-snapshot
Preclinical Biomarkers of Parkinson Disease
inferred← citeshttps://doi.org/10.1002/9783527655946.ch14openalex-snapshot
Lipid Metabolism in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1002/ana.24751openalex-snapshot
Statin therapy prevents the onset of Parkinson disease in patients with diabetes
inferred← citeshttps://doi.org/10.1002/ana.25614openalex-snapshot
Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow‐up
inferred← citeshttps://doi.org/10.1002/brb3.2454openalex-snapshot
Association of serum cholesterol with Parkinson's disease in a cohort of statin‐free individuals
inferred← citeshttps://doi.org/10.1002/jnr.23115openalex-snapshot
Vitamin D and Parkinson's disease
inferred← citeshttps://doi.org/10.1002/mds.22626openalex-snapshot
Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent?
inferred← citeshttps://doi.org/10.1002/mds.22705openalex-snapshot
Major nutritional issues in the management of Parkinson's disease
inferred← citeshttps://doi.org/10.1002/mds.22793openalex-snapshot
Reply: Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent?
inferred← citeshttps://doi.org/10.1002/mds.23102openalex-snapshot
Statin use and Parkinson's disease in Denmark
inferred← citeshttps://doi.org/10.1002/mds.26152openalex-snapshot
Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study
inferred← citeshttps://doi.org/10.1002/mds.26452openalex-snapshot
Plasma fasting cholesterol profiles and age at onset in P arkinson's disease
inferred← citeshttps://doi.org/10.1002/mds.27006openalex-snapshot
Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database
inferred← citeshttps://doi.org/10.1002/mds.27053openalex-snapshot
Linking statins and lipids in Parkinson's disease
inferred← citeshttps://doi.org/10.1002/mds.27390openalex-snapshot
Low‐fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial
inferred← citeshttps://doi.org/10.1002/mds.27413openalex-snapshot
Higher serum cholesterol and decreased Parkinson's disease risk: A statin‐free cohort study
inferred← citeshttps://doi.org/10.1002/mds.27609openalex-snapshot
Brain cholesterol metabolism and Parkinson's disease
inferred← citeshttps://doi.org/10.1002/mds.27836openalex-snapshot
Understanding the Links Between Cardiovascular Disease and Parkinson's Disease
inferred← citeshttps://doi.org/10.1002/pds.4079openalex-snapshot
Confounding of the association between statins and Parkinson disease: systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/pds.5015openalex-snapshot
Identifying drugs with disease‐modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology
inferred← citeshttps://doi.org/10.1007/978-3-031-42383-3_8openalex-snapshot
Lipid-Related Pathophysiology of ASD
inferred← citeshttps://doi.org/10.1007/s10072-014-1651-6openalex-snapshot
APOE and LRPAP1 gene polymorphism and risk of Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s10072-026-09070-9openalex-snapshot
When bad turns good: a systematic review on cholesterol and LDL in longitudinal patient cohorts with Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s10654-011-9581-6openalex-snapshot
Epidemiology and etiology of Parkinson’s disease: a review of the evidence
inferred← citeshttps://doi.org/10.1007/s10654-021-00730-yopenalex-snapshot
Heart rate, intelligence in adolescence, and Parkinson’s disease later in life
inferred← citeshttps://doi.org/10.1007/s11306-024-02100-7openalex-snapshot
Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases
inferred← citeshttps://doi.org/10.1007/s12035-021-02326-9openalex-snapshot
Role of Liver Growth Factor (LGF) in Parkinson’s Disease: Molecular Insights and Therapeutic Opportunities
inferred← citeshttps://doi.org/10.1007/s13311-019-00731-6openalex-snapshot
Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-323-95582-9.00008-5openalex-snapshot
Lipid metabolism in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.bbadis.2011.05.003openalex-snapshot
Physical and catalytic properties of a peroxidase derived from cytochrome c
inferred← citeshttps://doi.org/10.1016/j.bbr.2016.04.046openalex-snapshot
Statin use and risk of Parkinson’s disease: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.brainres.2016.02.049openalex-snapshot
Brain metabolism as a modulator of autophagy in neurodegeneration
inferred← citeshttps://doi.org/10.1016/j.csbj.2023.01.022openalex-snapshot
Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.ejim.2010.12.017openalex-snapshot
Nutrition and Alzheimer's disease: The detrimental role of a high carbohydrate diet
inferred← citeshttps://doi.org/10.1016/j.expneurol.2010.11.013openalex-snapshot
Statins — increasing or reducing the risk of Parkinson's disease?
inferred← citeshttps://doi.org/10.1016/j.ibneur.2022.09.007openalex-snapshot
The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease
inferred← citeshttps://doi.org/10.1016/j.jns.2009.09.021openalex-snapshot
Dietary fat intake and risk of Parkinson's disease: A case-control study in Japan
inferred← citeshttps://doi.org/10.1016/j.lfs.2022.121144openalex-snapshot
Lipid profile in Parkinson's disease: The potential role of brain-derived neurotrophic factor
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2011.05.016openalex-snapshot
Apolipoprotein E genotypes and the risk of Parkinson disease
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2022.02.011openalex-snapshot
Association between statin use and Parkinson's disease in Korean patients with hyperlipidemia
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2023.105881openalex-snapshot
Association between lipid levels and the risk of Parkinson's disease in individuals with diabetes mellitus: A nationwide population-based cohort study
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2024.107026openalex-snapshot
Update: Protective and risk factors for Parkinson disease
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2012.08.010openalex-snapshot
Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression
inferred← citeshttps://doi.org/10.1016/j.phrs.2009.03.010openalex-snapshot
Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's disease
inferred← citeshttps://doi.org/10.1016/s1474-4422(16)30230-7openalex-snapshot
The epidemiology of Parkinson's disease: risk factors and prevention
inferred← citeshttps://doi.org/10.1038/cdd.2011.105openalex-snapshot
Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease
inferred← citeshttps://doi.org/10.1038/ng.337openalex-snapshot
Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity
inferred← citeshttps://doi.org/10.1038/s41398-021-01580-8openalex-snapshot
Sterol and lipid analyses identifies hypolipidemia and apolipoprotein disorders in autism associated with adaptive functioning deficits
inferred← citeshttps://doi.org/10.1038/s41531-017-0015-3openalex-snapshot
Integrated molecular landscape of Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/s41531-021-00274-8openalex-snapshot
Metabolite and lipoprotein profiles reveal sex-related oxidative stress imbalance in de novo drug-naive Parkinson’s disease patients
inferred← citeshttps://doi.org/10.1038/s41531-024-00713-2openalex-snapshot
Metabolic profiling reveals circulating biomarkers associated with incident and prevalent Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/s41531-025-01003-1openalex-snapshot
Lower prevalence of metabolic syndrome and its components in the prediagnostic phase of Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/s41598-020-77415-1openalex-snapshot
Longitudinal analysis of premotor anthropometric and serological markers of Parkinson’s disease
inferred← citeshttps://doi.org/10.1038/s41598-022-25180-8openalex-snapshot
Association between serum lipid levels over time and risk of Parkinson’s disease
inferred← citeshttps://doi.org/10.1073/pnas.1324209111openalex-snapshot
Splice isoform and pharmacological studies reveal that sterol depletion relocalizes α-synuclein and enhances its toxicity
inferred← citeshttps://doi.org/10.1080/10408398.2018.1529653openalex-snapshot
Lipids as biomarkers of brain disorders
inferred← citeshttps://doi.org/10.1080/15622975.2017.1417636openalex-snapshot
Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study
inferred← citeshttps://doi.org/10.1093/eurheartj/ehaa1080openalex-snapshot
How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol
inferred← citeshttps://doi.org/10.1093/jpp/rgaa063openalex-snapshot
Novel therapeutic approaches for Parkinson’s disease by targeting brain cholesterol homeostasis
inferred← citeshttps://doi.org/10.1097/mol.0b013e328352dc5dopenalex-snapshot
Parkin in the regulation of fat uptake and mitochondrial biology
inferred← citeshttps://doi.org/10.1101/2024.12.06.24318632openalex-snapshot
Association of Vascular Risk Factors with the Risk of Parkinson’s Disease among Stroke Survivors—A Nationwide Population-Based Study
inferred← citeshttps://doi.org/10.1111/jch.12938openalex-snapshot
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease
inferred← citeshttps://doi.org/10.1136/jnnp-2014-310065openalex-snapshot
Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study
inferred← citeshttps://doi.org/10.1145/3097983.3098065openalex-snapshot
Prognosis and Diagnosis of Parkinson's Disease Using Multi-Task Learning
inferred← citeshttps://doi.org/10.1146/annurev.cellbio.042308.113313openalex-snapshot
α-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease
inferred← citeshttps://doi.org/10.1159/000381857openalex-snapshot
Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study
inferred← citeshttps://doi.org/10.1159/000480401openalex-snapshot
Exploring the Association between Statin Use and the Risk of Parkinson’s Disease: A Meta-Analysis of Observational Studies
inferred← citeshttps://doi.org/10.1159/000502292openalex-snapshot
A Narrative Review of Lifestyle Factors Associated with Parkinson’s Disease Risk and Progression
inferred← citeshttps://doi.org/10.1161/circresaha.119.314929openalex-snapshot
Lipids, Apolipoproteins, and the Risk of Parkinson Disease
inferred← citeshttps://doi.org/10.1172/jci44736openalex-snapshot
Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells
inferred← citeshttps://doi.org/10.1177/1877718x251367305openalex-snapshot
Body mass index, metabolically abnormal status, and incident Parkinson's disease: Data from the UK Biobank
inferred← citeshttps://doi.org/10.1177/25424823261475263openalex-snapshot
Blood lipids as accessible biomarkers for early dementia risk screening: Bridging diagnostic gaps in resource-limited settings
inferred← citeshttps://doi.org/10.1179/1743132813y.0000000277openalex-snapshot
Serum lipid levels are associated with the prevalence but not with the disease progression of multiple system atrophy in a Chinese population
inferred← citeshttps://doi.org/10.11817/j.issn.1672-7347.2024.230438openalex-snapshot
Early-onset Parkinson's disease with mutations in both the PRKN gene and the APOB gene: A case report.
inferred← citeshttps://doi.org/10.1186/s12944-020-01284-wopenalex-snapshot
A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson’s disease
inferred← citeshttps://doi.org/10.1201/b14361-3openalex-snapshot
Epidemiology
inferred← citeshttps://doi.org/10.12775/qs.2024.18.53301openalex-snapshot
What role do environmental factors play in the development of neurodegenerative diseases? A narrative review
inferred← citeshttps://doi.org/10.13070/rs.en.1.1127openalex-snapshot
Low serum uric acid and high HDL-c levels - but not body mass index - may be related to Parkinson’s disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0022854openalex-snapshot
Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP
inferred← citeshttps://doi.org/10.1371/journal.pone.0024211openalex-snapshot
An Exploratory Study on CLU, CR1 and PICALM and Parkinson Disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0035397openalex-snapshot
Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0038144openalex-snapshot
Transcriptional Activation of Low-Density Lipoprotein Receptor Gene by DJ-1 and Effect of DJ-1 on Cholesterol Homeostasis
inferred← citeshttps://doi.org/10.1371/journal.pone.0152564openalex-snapshot
Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis
inferred← citeshttps://doi.org/10.1371/journal.pone.0313631openalex-snapshot
No association between genetically predicted vitamin D levels and Parkinson’s disease
inferred← citeshttps://doi.org/10.14232/phd.10844openalex-snapshot
A Parkinson-kór epidemiológiája
inferred← citeshttps://doi.org/10.14336/ad.2015.1030openalex-snapshot
Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson’s Disease
inferred← citeshttps://doi.org/10.14748/bmr.v26.1543openalex-snapshot
Serum cholesterol and triglycerides in Parkinson’s disease and essential tremor
inferred← citeshttps://doi.org/10.1515/revneuro-2022-0093openalex-snapshot
Recent research progress on metabolic syndrome and risk of Parkinson’s disease
inferred← citeshttps://doi.org/10.1517/14740330902859956openalex-snapshot
Statins and the risk of Parkinson disease: an update on the controversy
inferred← citeshttps://doi.org/10.18502/cjn.v21i4.11721openalex-snapshot
Association between plasma PCSK9 levels and lipid profile in patients with Parkinson’s disease and comparison with healthy subjects
inferred← citeshttps://doi.org/10.18632/aging.103992openalex-snapshot
Metabolic alterations in plasma from patients with familial and idiopathic Parkinson’s disease
inferred← citeshttps://doi.org/10.21037/atm.2019.01.68openalex-snapshot
Association between carotid plaque and Parkinson’s disease
inferred← citeshttps://doi.org/10.2147/clep.s77676openalex-snapshot
Prevalence and characteristics of patients with low levels of low-density lipoprotein cholesterol in northern Denmark: a descriptive study
inferred← citeshttps://doi.org/10.2174/0115672050411466251014111557openalex-snapshot
Relation between Cerebrospinal Fluid Catecholamines and Vascular Risk Factors, Thyroid Function and Vitamins in Healthy Individuals and Patients with Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.22088/cjim.12.2.155openalex-snapshot
Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran.
inferred← citeshttps://doi.org/10.2478/orvtudert-2019-0009openalex-snapshot
Occurrence of internal diseases in the premotor phase of Parkinson’s disease by analyzing a large database covering a whole population
inferred← citeshttps://doi.org/10.3109/00207454.2014.979288openalex-snapshot
The serum lipid profile of Parkinson's disease patients: a study from China
inferred← citeshttps://doi.org/10.3109/9781841849096.002openalex-snapshot
Epidemiology
inferred← citeshttps://doi.org/10.3233/jpd-130196openalex-snapshot
Role of Serum Cholesterol in Parkinson's Disease: A Meta-Analysis of Evidence
inferred← citeshttps://doi.org/10.3233/jpd-150685openalex-snapshot
The Concept of Prodromal Parkinson’s Disease
inferred← citeshttps://doi.org/10.3233/jpd-181486openalex-snapshot
Decreased Cerebrospinal Fluid Aβ42 in Patients with Idiopathic Parkinson’s Disease and White Matter Lesions
inferred← citeshttps://doi.org/10.3233/jpd-212670openalex-snapshot
Blood Cholesterol Decreases as Parkinson’s Disease Develops and Progresses
inferred← citeshttps://doi.org/10.3233/jpd-212984openalex-snapshot
Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder
inferred← citeshttps://doi.org/10.3389/fgene.2022.963163openalex-snapshot
Intelligence, education level, and risk of Parkinson’s disease in European populations: A Mendelian randomization study
inferred← citeshttps://doi.org/10.3389/fnagi.2020.00053openalex-snapshot
Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson’s Disease Severity
inferred← citeshttps://doi.org/10.3389/fnagi.2026.1841547openalex-snapshot
Serum total cholesterol and low-density lipoprotein cholesterol are associated with Parkinson’s disease in East Asian populations: a bidirectional Mendelian randomization study with complementary animal observation
inferred← citeshttps://doi.org/10.3389/fneur.2017.00501openalex-snapshot
Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson’s Risk
inferred← citeshttps://doi.org/10.3389/fneur.2020.00597openalex-snapshot
Effects of Higher Serum Lipid Levels on the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3389/fneur.2022.940118openalex-snapshot
Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study
inferred← citeshttps://doi.org/10.3389/fnins.2019.00328openalex-snapshot
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
inferred← citeshttps://doi.org/10.3389/fnmol.2017.00120openalex-snapshot
PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease
inferred← citeshttps://doi.org/10.3390/cells12030385openalex-snapshot
Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
inferred← citeshttps://doi.org/10.3390/cells8010027openalex-snapshot
The Role of Lipids in Parkinson’s Disease
inferred← citeshttps://doi.org/10.3390/jcm15166406openalex-snapshot
Vascular Risk Factors and the Risk of Incident Parkinson’s Disease Among Stroke Survivors: A Nationwide Population-Based Cohort Study
inferred← citeshttps://doi.org/10.3390/proteomes10010004openalex-snapshot
Potential Tear Biomarkers for the Diagnosis of Parkinson’s Disease—A Pilot Study
inferred← citeshttps://doi.org/10.35366/120411openalex-snapshot
Estudio del microsatélite Rep-1 del gen alfa sinucleína en pacientes con la enfermedad de Parkinson idiopática
inferred← citeshttps://doi.org/10.3945/ajcn.114.085027openalex-snapshot
Interactions between genetic variants and dietary lipid composition: effects on circulating LDL cholesterol in children
inferred← citeshttps://doi.org/10.4061/2010/836962openalex-snapshot
Total Cholesterol and the Risk of Parkinson's Disease: A Review for Some New Findings
inferred← citeshttps://doi.org/10.53846/goediss-8398openalex-snapshot
Der Einfluss von humanem Wildtyp-Alpha-Synuclein und seinen Mutationen A30P und A53T auf das Neuritenwachstum primärer dopaminerger Mittelhirnneurone der Ratte
inferred← citeshttps://doi.org/10.7156/v2i3p102openalex-snapshot
Vascular Risk Factors and the Risk of Parkinson's Disease: Some New Findings
inferred← citeshttps://doi.org/10.7156/v3i1p073openalex-snapshot
Environmental Epidemiology of Sporadic Parkinson�s Disease
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.